Literature DB >> 1998862

Prolonged intermittent clamping of the portal triad during hepatectomy.

D Elias1, E Desruennes, P Lasser.   

Abstract

From 112 consecutive hepatectomies for malignant tumours performed with intermittent portal triad clamping, we have retrospectively selected the 20 cases in which clamping exceeded 90 min. Intermittent portal clamping of prolonged duration was used because of abnormal liver texture in 13 cases (mainly patients who had received intra-arterial chemotherapy) and/or because of technically difficult hepatectomy. The mean(s.d.) duration of intermittent portal clamping was 109(18) min and in two cases it exceeded 140 min (148 and 150 min). There was no postoperative mortality and the rate of postoperative morbidity was 35 per cent. Postoperative changes in biochemical liver tests were not major and transient hepatic failure occurred in only one patient following subtotal resection of the liver. We conclude that intermittent portal clamping is a useful manoeuvre in partial hepatectomy when resection is difficult or prolonged, or when the liver parenchyma is abnormal. Such clamping may be used for longer than 120 min without major complications.

Entities:  

Mesh:

Year:  1991        PMID: 1998862     DOI: 10.1002/bjs.1800780115

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

1.  Hepatic vascular exclusion with preservation of the caval flow for liver resections.

Authors:  D Cherqui; B Malassagne; P I Colau; F Brunetti; N Rotman; P L Fagniez
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

2.  Forty-nine colorectal cancer liver metastases in one-stage hepatectomy with cumulative Pringle time lasting 348 min.

Authors:  Fabio Procopio; Guido Torzilli
Journal:  Updates Surg       Date:  2012-03-06

3.  Outcome using hemihepatic vascular occlusion versus the pringle maneuver in resections limited to one hepatic section or less.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Shinji Togo; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

Review 4.  How much ischemia can the liver tolerate during resection?

Authors:  Wouter G van Riel; Rowan F van Golen; Megan J Reiniers; Michal Heger; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

5.  Techniques of hepatic resection.

Authors:  Robert J Aragon; Naveenraj L Solomon
Journal:  J Gastrointest Oncol       Date:  2012-03

6.  Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Authors:  Hannes A Rüdiger; Koo J Kang; David Sindram; Hans M Riehle; Pierre A Clavien
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

7.  A multicentre controlled study of the InLine radiofrequency ablation device for liver transection.

Authors:  Peng Yao; Frank Chu; Steve Daniel; Aravin Gunasegaram; Tristan Yan; Werner Lindemann; Georg Pistorius; Martin Schilling; Junji Machi; Randall Zuckerman; David L Morris
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study.

Authors:  Vassilios E Smyrniotis; Georgia G Kostopanagiotou; John C Contis; Charalampos I Farantos; Dionisios C Voros; Dimitrios C Kannas; John S Koskinas
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

Review 9.  Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and meta-analysis.

Authors:  Nuh N Rahbari; Moritz Koch; Arianeb Mehrabi; Kathrin Weidmann; Edith Motschall; Christoph Kahlert; Markus W Büchler; Jürgen Weitz
Journal:  J Gastrointest Surg       Date:  2008-07-12       Impact factor: 3.452

10.  Laparoscopic hepatectomy versus open hepatectomy for colorectal cancer liver metastases: comparative study with propensity score matching.

Authors:  Xavier Untereiner; Audrey Cagniet; Riccardo Memeo; Stylianos Tzedakis; Tullio Piardi; François Severac; Didier Mutter; Reza Kianmanesh; Jacques Marescaux; Daniele Sommacale; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.